Search for: "Patent Docs"
Results 781 - 800
of 1,638
Sorted by Relevance
|
Sort by Date
28 Oct 2009, 6:15 am
Holdings v Metabolite Labs (Patent Baristas) US: BIO's IPCC Conference: Patent re-examination in the life sciences (Patent Baristas) US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics) US:… [read post]
28 Oct 2009, 7:15 am
Holdings v Metabolite Labs (Patent Baristas) US: BIO’s IPCC Conference: Patent re-examination in the life sciences (Patent Baristas) US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics)… [read post]
15 Dec 2010, 2:17 am
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs)… [read post]
16 Nov 2009, 11:25 pm
There was a link to Patent Docs, which discussed the CAFC decision, but which did not mention the name Dudas. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following… [read post]
8 Oct 2008, 8:32 am
There was a certain inventorship case in CD Cal, discussed by, among others, Patent Docs, who wrote:On June 9, 2008, the University of Pittsburgh obtained a judgment correcting inventorship of U.S. [read post]
4 Aug 2010, 12:21 am
(Patent Docs) [read post]
15 Apr 2011, 6:54 am
Patent Docs has a detailed post on yesterday’s proceedings. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against… [read post]
31 Aug 2011, 2:30 am
X ZR 68/08 (IPKat) Myfortic (Mycophenolate sodium) – US: Novartis and Apotex resolve patent dispute over Myfortic (Patent Docs) Ofirmev (Acetaminophen) – US: Cadence Pharmaceuticals files patent infringement suits in W D North Carolina, W D Michigan, Minnesota and Delaware against Exela, Paddock and Perrigo following Para IV certification (Patent Docs) Patanase (Olopatadine) – US: Alcon files patent infringement suit… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim… [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court… [read post]
8 Feb 2011, 10:51 pm
Kohl introduces bill to prohibit reverse payments (Patent Docs) US: Office of Generic Drugs finished 2010 on a high note – really high! [read post]
28 Sep 2010, 3:14 pm
(Patent Docs) [read post]
21 Aug 2010, 10:29 am
Zeropaid suggested a posting on Slashdot suggested that Apple is trying to patent (through the “Systems And Methods for Identifying Unauthorized Users of An Electronic Device” patent [application]) the ability to remotely disable jailbroken phones. [read post]
24 Aug 2011, 12:33 am
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
26 Mar 2007, 5:09 pm
This also appears to be contrary to the USPTO's own privacy policy http://www.uspto.gov/web/doc/privact.htm>, which discloses the use of cookies for other USPTO systems, but not for public PAIR. [read post]
1 Jun 2016, 10:00 pm
Link to the Federal Advisory Circuit Model Order, courtesy of Patently-O: http://patentlyo.com/media/docs/2013/07/model-order-excess-claims.pdf [read post]
10 Aug 2011, 4:30 am
(Patent Docs) [read post]
